...Hired: Stacey Channing, as VP, patent and legal counsel; formerly VP and general counsel for ImmuLogic Pharmaceutical Corp....

...a trial of Allevax Ragweed this summer, while continuing work on the cat allergy product. ImmuLogic Pharmaceutical Corp....

...rights to TA-CD and TA-NIC vaccines to treat cocaine addiction and nicotine addiction, respectively, from ImmuLogic's...

...buy back remaining milestone and royalty rights to TA-CD and TA-NIC drug addiction vaccines from ImmuLogic's...
...1998 deal, Cantab Pharmaceuticals plc , (Cambridge, U.K.), which merged with XEN in 2001, acquired ImmuLogic's...
...to cholera toxin B subunit, is in a Phase I trial to treat nicotine addiction. ImmuLogic...

...buy back remaining milestone and royalty rights to TA-CD and TA-NIC drug addiction vaccines from ImmuLogic's...
...liquidation trust. Under a 1998 deal, Cantab Pharmaceuticals, which merged with XEN in 2001, acquired ImmuLogic's...
...to cholera toxin B subunit, is in a Phase I trial to treat nicotine addiction. ImmuLogic...

...folding up the tent and giving back money to their shareholders, as he coached ImmuLogic Pharmaceutical Corp....
...do in 1999. "When I was at H&Q with Dennis Purcell, we got hired by ImmuLogic...
...cash, then let's give it back to the shareholders and let them decide." In 1999, ImmuLogic's...

...$651.20 Igen (IGEN) $86.80 $74.80 $201.40 $467.10 $392.80 ImClone (IMCL) $113.00 $196.10 $196.60 $220.20 $574.50 ImmuLogic...
...$651.20 Igen (IGEN) $86.80 $74.80 $201.40 $467.10 $392.80 ImClone (IMCL) $113.00 $196.10 $196.60 $220.20 $574.50 ImmuLogic...

...operations because of contingencies and lack of specifics in the proposal (see BioCentury, Aug. 23). ImmuLogic Pharmaceutical Corp....

...operations. Earlier this year, IMUL's board voted to liquidate the company (see BioCentury, April 5). ImmuLogic Pharmaceutical Corp....